Rochester, NY 6/16/2009 11:30:46 PM
Afternoon Gainers NASDAQ - PSTI,APKT,ESLR - Sourced WhisperFromWallStreet.com
Pluristem Therapeutics, Inc. - Acme Packet, Inc. - Evergreen Solar, Inc.
Afternoon Gainers NASDAQ - PSTI,APKT,ESLR - Sourced WhisperFromWallStreet.com
WhisperfromWallStreet.com is an award winning newsletter that specializes in sending alerts to our subscribers on stocks we think are going to run, why we think so, and teaching you how to become a better trader. We can now even deliver this information instantly to our "Penny Stock Alert" gadget that sits right on your Microsoft Vista or iGoogle desktop. You will know from the instant you get your confirmation email that we are different. What do you have to lose except a little time and a chance to really learn how to make money trading.
Sign up for our FREE alerts at WhisperfromWallStreet.com
---
Pluristem Therapeutics, Inc.,PSTI
1.41 Up 0.13 (10.16%) 11:50am ET
-Pluristem Therapeutics Inc., a bio-therapeutics company dedicated to the commercialization of unrelated donor-patient (allogeneic) cell therapy products for a variety of disorders, announced today that the Paul Ehrlich Institute (PEI), the German competent authority in the European Union, has approved the Company’s Clinical Trial Application (CTA) and granted approval to begin clinical trials with its placental-derived adherent stromal cell product, termed PLX-PAD, for the treatment of critical limb ischemia (CLI), the end-stage of peripheral artery disease (PAD). In addition, Pluristem has already received approval from the Ethics Committee and, as previously announced, the US Food & Drug Administration (FDA) had cleared the Company’s Investigational New Drug (IND) application to initiate a similar trial in the United States. Both approvals of the CTA and IND clear the way for the world’s "first-in-man" clinical trial using PLX-PAD.
ABOUT
Pluristem Therapeutics, Inc., a bio-therapeutics company, engages in the production, research, and development of placental-derived adherent stromal cells (ASCs). The company also involves in the commercialization of non-personalized (allogeneic) cell therapy products for the treatment of various severe degenerative, ischemic, and autoimmune disorders. It develops a pipeline of products that are derived from the human placenta, a non-controversial, non-embryonic, adult stem cell source.
Last Trade: 1.41
Day's Range: 1.40 - 1.49
52wk Range: 0.26 - 2.29
Volume: 77,197
---
Acme Packet, Inc.,APKT
8.72 Up 0.71 (8.86%) 12:16pm ET
Acme Packet, Inc. provides session border controllers (SBC) that enable service providers, enterprises, and contact centers to deliver interactive communications and data services across Internet protocol (IP) network borders. The SBCs are deployed at the borders of IP networks, such as between two service providers; between a service provider and its enterprise, residential, or mobile customers; or between a server provider?s network and a data center. The SBCs act as the source and destination for signaling messages and media streams entering and exiting the network.
Last Trade: 1.74
Day's Range: 1.50 - 1.88
52wk Range: 0.01 - 4.95
Volume: 324,958
---
Here are a few alerts our WhisperfromWallStreet.com subscribers enjoyed.
SPNG 1000%
AMNG 241%
RKBD 300%
UTRM 169%
TLLE 266%
Sign up to receive free stock alerts
---
Evergreen Solar, Inc.,ESLR
2.54 Up 0.16 (6.72%) 12:20pm ET
Hiring is underway at Evergreen Solar Inc.'s new $55 million plant in Midland, which will make silicon components for solar panels.
The Marlboro, Mass.-based company last month completed a $72.5 million stock sale, partly to raise money for the Midland plant. Last year, the project got a tax credit from the Michigan Economic Development Corp.
ABOUT
Evergreen Solar, Inc. engages in the development, manufacture, and marketing of solar power products primarily in the United States and Europe. It utilizes its proprietary "String Ribbon" technology process to produce multi-crystalline silicon wafers by growing thin strips of multi-crystalline silicon that are then cut into wafers. These wafers are the primary components of photovoltaic cells that are used to produce solar panels.
Last Trade: 2.51
Day's Range: 2.46 - 2.68
52wk Range: 1.00 - 12.64
Volume: 7,279,028
---
Disclaimer: Full disclaimer at http://whisperfromwallstreet.com/disclaimer.php
WhisperfromWallStreet.com (WFWS) based upon information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by WFWS to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. WFWS is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on http://www.whisperfromwallstreet.com or mentioned herein. WFWS may have been compensated with shares or with cash from third party shareholders or the company on behalf of one or more of the companies mentioned in this opinion.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and WFWS undertakes no obligation to update such statements.
This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
CONTACT: WhisperFromWallStreet.com
